Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACP-01 in critical limb ischemia
NCT02551679Phase 2Completed
- Sponsor
- Hemostemix Inc.
- Start
- Aug 2014
- Primary completion
- Apr 2020
- Countries
- 2
01
Overview
A Phase 2 trial of autologous angiogenic cell precursors in critical limb ischemia (CLI), sponsored by Hemostemix Inc.. Started Aug 2014; status: completed.
02
Drugs
autologous angiogenic cell precursors
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02551679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02551679.